Martin Alan Menter

16PUBLICATIONS
19CO-AUTHORS
Rheumatology and arthritisBiomaterialsClinical pharmacology and therapeuticsRespiratory diseasesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 05, 2024
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial).

Bruce Strober, Hervé Bachelez, Jeffrey Crowley

|Aug 07, 2022
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial.

Alan Menter, Stanley Cohen, Jonathan Kay

|Jun 07, 2022
Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis.

Alan Menter, Tina Bhutani, Benjamin Ehst

|May 06, 2021
Penile calciphylaxis with extragenital gangrene.

Marcus Zaayman, Annika Silfvast-Kaiser, Edgar Rodriguez

|Dec 15, 2020
Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study.

Alan Menter, Petr Arenberger, Sigrid Balser

|Nov 02, 2020
Ixekizumab in the treatment of moderate-to-severe plaque psoriasis: Patient adherence, satisfaction, and preferences.

Aaminah Azhar, Marcus Zaayman, Annika Silfvast-Kaiser

Pageof 3

Frequent Collaborators

4 joint publications

Annika Silfvast-Kaiser

3 joint publications

Marcus Zaayman

1 joint publications

D Kivelevitch

1 joint publications

P Michel